Kirk, P. S., Koreckij, T., Nguyen, H. M., Brown, L. G., Snyder, L. A., Vessella, R. L., & Corey, E. (2013). Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone. Molecular Diversity Preservation International (MDPI).

Kirk, Peter S., Theodore Koreckij, Holly M. Nguyen, Lisha G. Brown, Linda A. Snyder, Robert L. Vessella, und Eva Corey. Inhibition of CCL2 Signaling in Combination With Docetaxel Treatment Has Profound Inhibitory Effects On Prostate Cancer Growth in Bone. Molecular Diversity Preservation International (MDPI), 2013.

Kirk, Peter S., et al. Inhibition of CCL2 Signaling in Combination With Docetaxel Treatment Has Profound Inhibitory Effects On Prostate Cancer Growth in Bone. Molecular Diversity Preservation International (MDPI), 2013.